Abstract
10 consecutive patients with HSV-associated chronic oral lesions were treated with Egiferon for ten days. There were a statistically significant increase in the Large Granule Lymphocyte (LGL) counts and the number of spontaneous E rosette forming cells by the end of the treatment period. Interferon alpha brought about a preferential expression of CD8, CDllb, CD14, CD25 and CD45RO cell surface molecules without any effect on the expression of CD2, CD3, CD4, CD20 and HLA-DR.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexander GJ, BrahmJ and laganE: Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 2:66–69, 1987.
Benius AJ, von MoorsebaarRJ, Peelen WP et al Differential sensitivity of renal carcinoma xenograft therapy with interferon alpha and gamma tumor necrosis factor and combinations. Urol Res 19:91–98, 1991.
Brunetto MR, OliveriF and BoninoF: Natural course and response to interferon of chronic hepatitis B accompained by antibody to hepatitis B antigen. Hepatology 10:198–202, 1989.
CantelK and TomillaV: Effect of interferon on experimental vaccina and herpes simplex virus infection in rabbits eyes. Lancet 2:682–684, 1960.
CantelK: Clinical performance of natural human leukocyte interferon. Immunbiol 172:231–242, 1986.
DameshekW: Chronic lymphocytic leukaemia: an accumulation disease of immunological incompetent lymphocytes. Blood 29:566–581, 1967.
DeClerq E and Srewart WE: Selective inhibition of virus function. (Ed: Carter WA) pp. 43–69. CRC Press Co. 1987.
Foon KA, Maluish AE, Abrams PG et al: Recombinant leukocyte interferon therapy for advanced hairy cell leukaemia. Therapeutic and immunological results. Amer J Med 80:351- 358,1986.
Griffits SB, Galvani BW and Covley JC: The Interferons In: Immunology of diseases, pp. 43–69 ({EDEd}: Hamilton TJ) Kulwer Academic Press 1989 London U.K.
Ikeda T, Lever AM and Thomas HC: Evidence for deficiency of interferon production in patients with chronic hepatitis B virus infection aquired in adult life. Hepatology 6:962–965, 1986.
Jondal M, HolmH and WigzellH: Surface markers on human T and B lymphocytes. J Exp Med 136:207–211, 1972.
Keating MR: Antiviral agents. Mayo Clin Proc 67:160–178, 1992.
Kövesi G, Pálóczy K, OnódyK et al: Natural human alpa interferon in the treatment of oral virus infections. Lege Artis Med 3:1020–1027, 1993. (In Hungarian)
Melen K, KrugR and JulkunenI: Multiclonal activity of interferon induced influenza virus resistance gene Mx: structural requirements for antiviral activity. J Interferon Res 11: (Suppll) S190, 1991.
Miller CS: Diagnosis and management of orofacial herpes simplex virus infection. Dent Clin North Am 36:879–895, 1992.
Pangalis GA and Grina E: Recombinant alpha 2b interferon therapy in untreated stages A and B chronic lymphocytic leukaemia. Cancer 61:69–672, 1988.
Poppema S, LaiR and VisserL: Monoclonal antibody OPD4 is reactive with CD 45RO but differs from UHCL-1 by the absence of monocyte reactivity. Am J Pathol 139:725–729, 1991.
Patapoulous GM, Orphanou KM, LongaF, et al: Alpha interferon therapy in patients with chronic active hepatitis B. Immunological profile. J Invest Allergol Clin Immunol 1:330–331, 1991.
SillisM: Clinical evaluation of enzyme immunoassay in rapid diagnosis of herpes simplex infections. J Clin Pathol 45:165–167, 1992.
Spurance SL: The natural history of recurrent orofacial herpes simplex virus infection. Semin Dermatol 11:200–206, 1992.
Stewart WE: Varied biologic effects of interferon treatment. Interferon Vol 1:29-51 Acad Press 1979.
Talpaz M, Rosenblum Mand KurczrockR: Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukaemia. Am J Haematol 2:341–350, 1987.
Talpaz M, Rosenblum M, KurczrockR, et al: Therapy of chronic mylogenous leukaemia. Chemotherapy and Interferons. Semin Haematol 25:62–73, 1988.
WybranJ and Fudenberg HH: Thymus derived rosette forming cells in various human states: cancer, lymphoma, bacterial and viral infections and other diseases. J Clin Invest 52:1026–1034, 1973.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
KÖvesi, G., PÁlÓczi, K., Ónody, K. et al. Immunologie profile of patients suffering from herpes simplex virus (HSV) -associated oral lesions treated with natural human interferon alpha (Egiferon). Pathol. Oncol. Res. 3, 44–46 (1997). https://doi.org/10.1007/BF02893352
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02893352